Trial Profile
Evaluating Efficacy and safety of deferasirox in the reduction of serum ferritin and transaminases in acute leukemia patients in remission who have treated with intensive chemotherapy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Dec 2015
Price :
$35
*
At a glance
- Drugs Deferasirox (Primary)
- Indications Leukaemia
- Focus Therapeutic Use
- 29 Dec 2015 New trial record